 |
The exhibition will be open continuously on both days. Delegates will also be able to arrange partnering meetings
at any time during the conference.
You can read speaker profiles by clicking on the speakers whose names are underlined.
You can also download the programme by clicking here 
Wednesday 19 May
| 09:30 |
Session I: The Biotechnology Challenge
Chaired by Dr Malcolm Simms, Director of Innovation and Enterprise at Queen Mary University of London.
|
|
| |
Capturing Value in Life Science Innovation
Dr Roger Harrison, VP, Head of Oncology Strategic Business Unit, BTG Plc.
|
| 10:10 |
Company Presentations 1
Alternative strategy to establish a drug delivery company
Dr Andrew Muddle, CEO, MedPharm Ltd.
GeneICE - new therapeutic approach
Dr Jake Micallef, Director, Cronos Therapeutics.
|
| 11:00 |
Session II: The Convergence Challenge
Chaired by Sue Harris, Managing Director, Andersen Piquet.
|
|
| |
Bioinformatics and Computational Systems Biology Workshops and Projects
Dr Frederic Marcus, Principal Scientific Officer, European Commission.
Research Directorate.
Oracle'e Strategy in Life Sciences.
Susie Stephens, Principal Product Manager, Oracle Life Sciences (USA).
|
| 12:00 |
Company Presentations 2
Bringing together biosciences, microelectronics and informatics to detect and manage chronic diseases
James Jackson, CEO, Smart Sensor Telemed.
How much are your databases worth?
Dr. Lewis Jardine, Engineering Director, Intellidos Ltd
|
| 14:15 |
Session III: Ahead of the game Part 1
Chaired by
Prof. Igor Goryanin, Head, Cell Simulations and Pathway Modelling, GlaxoSmithKline
Visiting Professor, University College London
Maximising the value of experimental and in silico screening.
Dr Jin Li, Director, Chemical Computing Enabling Science and Technology
(EST) AstraZeneca R&D Mölndal, Sweden.
|
| 15:00 |
Session IV: The Business Challenge Part 1:
Chaired by John Pool, founder of Proteus International Plc and Biotechnology business advisor to Scottish Enterprise
|
|
| |
Bridging the Equity Gap
Dr Louis Nisbet, Partner, Sitka Partners
Venture Capital - the Nordic Model
Seppo Mäkinen, Senior Partner, Bio Fund Management Ltd
|
| 16:10 |
The Business Challenge Part 2: |
|
| |
Route to the IPO
Dr Jonathan Kwok, Life Science Analyst
|
| 17:00 |
Drinks reception in the exhibition hall |
| 18:30 |
Conference Dinner on the Barbican Terrace |
Thursday 20 May
| 09:45 |
Session V: Cracking the code
Chaired by Prof. Nick Lemoine, Director of The Cancer Research UK Clinical Centre.
|
|
| |
Bioinformatics and Data Resources
Prof. Janet Thornton, Director of The European Bioinformatics Institute and founder of Inpharmatica.
Breaking the surface: genetics, genomics and epithelial disease.
Prof. William O.C.M. Cookson, Wellcome Trust Centre for Human Genetics,
University of Oxford and founder of Surface Therapeutics.
|
| 10:35 |
Company Presentations 3
Open Discovery Workflows: a pragmatic approach to integrating bioinformatics and cheminformatics.
Dr. Jonathan Sheldon, Chief Scientific Officer (LifeSciences), InforSense, UK.
Machine Learnt Biomarkers
Prof. Vijay Chandru, CEO, Strand Genomics, India.
|
| 12:00 |
Session VI: Collaboration model
Chaired by Prof. Charles Barden-Fuller, Professor of Strategy and International Business, Cass Business School.
|
|
| |
Maximising value from integrated PK-PD Prediction
Jörg Lippert, Bayer Technology Services, Computational Solutions.
Applying integrated PK-PD Modeling along the value chain
John Savin, CEO, Physiomics. |
| 14:00 |
Session VII: Ahead of the game Part 1:
Chaired by Prof. Colin Howard, Director, London BioScience Innovation
Centre and Vice Pricipal of Royal Veterinary College.
|
|
| |
Turning ideas into sustainable business.
Anne Marie Dalgaard, Partner Promotion Group Manager, ISTC, Russia.
Developing the in silico cell: a tool for
drug therapy design.
Prof. David Fell, Professor
of Biochemistry and Assistant Dean of
the School of Biological & Molecular
Sciences, Oxford Brookes University.
|
| 15:15 |
Ahead of the game Part 2:
"Mind the Gap" - ITI as an innovative model for economic development
Dr John Chiplin, CEO, ITI Life Sciences
Biology,Bioconvergence - Information and Life - Putting it all Together
Prof. Alan Barrell, Chairman,
Cambridge Worldwide Associates and Transitions Ltd, Entrepreneur
in residence, Cambridge University.
Closing remarks and discussion.
|
|
| |
| |
Please contact us to showcase your company
or technology.
|
| |
 |
|
|
